Showing results (291-300 of 590) with videos related to

Sort By:
Pageof 59
Pharmaceutical Research|May 1, 1994
The effect of immunosuppression by total-body irradiation on the pharmacodynamics of centrally active drugs in ratsA Hoffman, J Alfon, G Habib, et al.
Pharmacology, Biochemistry, and Behavior|October 1, 1994
Differential effects of various antiinflammatory drugs on theophylline neurotoxicityA Hoffman, M Afargan, E Pinto, et al.
Psychopharmacology|January 1, 1989
Controlled comparison of two doses of milnacipran (F 2207) and amitriptyline in major depressive inpatientsM Ansseau, R von Frenckell, C Mertens, et al.
Blood Cells, Molecules & Diseases|May 15, 1998
Distinct haplotype in non-Ashkenazi Gaucher patients with N370S mutationO Amaral, A Marcão, E Pinto, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|September 1, 2006
DNA flow cytometry but not telomerase activity as predictor of disease-free survival in pT1-2/N0/G2 breast cancerAntónio E Pinto, Saudade André, Teresa Pereira, et al.
Il Giornale Di Chirurgia|April 28, 1999
[Clinicopathological features of advanced gastric cancer. Report on 400 operated cases]A De Stefano, F Roviello, D Marrelli, et al.
Oncology Reports|September 25, 2008
Aneuploidy and high S-phase as biomarkers of poor clinical outcome in poorly differentiated and anaplastic thyroid carcinomaAntónio E Pinto, Giovani Silva, Ana Banito, et al.
The International Journal of Biological Markers|April 18, 2003
Overall survival in advanced breast cancer: relevance of progesterone receptor expression and DNA ploidy in fine-needle aspirates of 392 patientsA E Pinto, S André, E Mendonça, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2001
C-erbB-2 oncoprotein overexpression identifies a subgroup of estrogen receptor positive (ER+) breast cancer patients with poor prognosisA E Pinto, S André, T Pereira, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|December 19, 2007
Male and female breast cancer--differences in DNA ploidy, p21 and p53 expression reinforce the possibility of distinct pathways of oncogenesisSaudade André, António E Pinto, Cátia Laranjeira, et al.
Pageof 59